✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Emcure Pharmaceuticals Ltd.

EMCURE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹25,666 Cr.
P/E
34.49

Emcure Pharmaceuticals Ltd.

  • Emcure Pharma
  • Wockhardt
  • JB Chem & Pharma

FAQs on Emcure Pharmaceuticals Ltd. Shareprice

Emcure Pharma has given lower returns compared to its competitors.
Emcure Pharma has grown at ~-9.28% over the last 1yrs while peers have grown at a median rate of 4.0%

Emcure Pharma is not expensive.
Latest PE of Emcure Pharma is 34.51, while 3 year average PE is 45.57.
Also latest EV/EBITDA of Emcure Pharma is 16.89 while 3yr average is 18.13.

View FAQ's On Business

Growth Table

  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Balance Sheet

  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Cash Flow

  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Quarterly Results

  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • JB Chem & Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Emcure Pharmaceuticals Ltd. Financials

Balance sheet of Emcure Pharma is strong.
But short term working capital might become an issue for this company.

The net debt of Emcure Pharma is decreasing.
Latest net debt of Emcure Pharma is ₹400 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1,608 Crs.

Yes, profit is increasing.
The profit of Emcure Pharma is ₹770 Crs for TTM, ₹681 Crs for Mar 2025 and ₹498 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Emcure Pharma latest dividend payout ratio is 10.91% and 3yr average dividend payout ratio is 8.85%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech